CHKP
Check Point Software Technologies Ltd.
CHKP has lower modeled downside risk, despite its lower overall score.
PLTR
Palantir Technologies Inc.
PLTR has the edge over CHKP overall, supported by stronger fundamentals and stronger modeled upside.
CHKP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Stable |
CHKP's profitability and cash flow are currently strong, and its revenue and balance sheet are stable.
PLTR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
PLTR's revenue, profitability, cash flow and balance sheet are all currently strong.
CHKP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $147 | — |
| Current | 15x | $147 | — |
| Cheap | 19x | $187 | +26% |
| Fair | 21x | $203 | +38% |
| Expensive | 25x | $241 | +64% |
Historical ranges are pointers, not guarantees.
CHKP's PE is in its cheap range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
PLTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 75x | $172 | — |
| Current | 120x | $172 | — |
| Cheap | 165x | $236 | +37% |
| Fair | 251x | $359 | +109% |
| Expensive | 452x | $646 | +277% |
Historical ranges are pointers, not guarantees.
PLTR has the edge over CHKP in the historical PE scenario, which offers more potential upside but is not a forecast.
CHKP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect CHKP's earnings to grow and its profitability to improve, with its revenue holding steady.
PLTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
PLTR has the edge over CHKP on the outlook, with more favorable revenue expectations.
CHKP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.74 | +10% |
| Q2 2026 | $9.73 | +27% |
| Q1 2026 | $9.70 | +28% |
| Q4 2025 | $9.60 | +29% |
| Q3 2025 | $9.13 | +25% |
| Q2 2025 | $7.68 | +6.1% |
| Q1 2025 | $7.58 | +5.4% |
| Q4 2024 | $7.47 | +5.1% |
| Q3 2024 | $7.32 | +2.2% |
CHKP's earnings per share have climbed steadily: $9.73 over the past year, up 27% from the year before, and higher year over year for 16 quarters in a row.
PLTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.30 | +61% |
| Q3 2026 | $1.43 | +240% |
| Q2 2026 | $1.17 | +290% |
| Q1 2026 | $0.89 | +287% |
| Q4 2025 | $0.63 | +232% |
| Q3 2025 | $0.42 | +110% |
| Q2 2025 | $0.30 | +76% |
| Q1 2025 | $0.23 | +92% |
| Q4 2024 | $0.19 | +111% |
PLTR has the edge over CHKP on earnings, with stronger typical year-over-year growth.
CHKP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $673.6M | +1.3% |
| Q1 2026 | $668.4M | +4.8% |
| Q4 2025 | $744.9M | +5.9% |
| Q3 2025 | $677.5M | +6.7% |
| Q2 2025 | $665.2M | +6% |
| Q1 2025 | $637.8M | +6.5% |
| Q4 2024 | $703.7M | +6.1% |
| Q3 2024 | $635.1M | +6.5% |
CHKP's revenue has grown year over year every quarter since late 2020: $674M last quarter, up 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 27% | -3.1 points |
| Q1 2026 | 28% | -3 points |
| Q4 2025 | 31% | -4.9 points |
| Q3 2025 | 29% | -5 points |
| Q2 2025 | 31% | -2.8 points |
| Q1 2025 | 31% | -1.7 points |
| Q4 2024 | 36% | -1.8 points |
| Q3 2024 | 34% | -3.5 points |
CHKP's operating margin was 27% last quarter, down 3.1 points from the same quarter a year ago, near the bottom of its range since 2019.
PLTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | +96% |
| Q2 2026 | $1.9B | +93% |
| Q1 2026 | $1.6B | +85% |
| Q4 2025 | $1.4B | +70% |
| Q3 2025 | $1.2B | +63% |
| Q2 2025 | $1B | +48% |
| Q1 2025 | $883.9M | +39% |
| Q4 2024 | $827.5M | +36% |
PLTR has the edge over CHKP on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +14 points |
| Q2 2026 | 47% | +20 points |
| Q1 2026 | 46% | +26 points |
| Q4 2025 | 41% | +40 points |
| Q3 2025 | 33% | +18 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 20% | +7.2 points |
| Q4 2024 | 1.3% | -9.5 points |
PLTR has the edge over CHKP on profitability, with a higher operating margin.
CHKP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $160.7M | -37% |
| Q1 2026 | $435.9M | +5.4% |
| Q4 2025 | $277.3M | +17% |
| Q3 2025 | $265.1M | +8.6% |
| Q2 2025 | $256M | +32% |
| Q1 2025 | $413.7M | +17% |
| Q4 2024 | $236.1M | +0.8% |
| Q3 2024 | $244.1M | +13% |
CHKP's free cash flow has been positive every quarter for seven years: $1.1B over the past year, about the same as the year before.
PLTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +139% |
| Q2 2026 | $1.2B | +126% |
| Q1 2026 | $891.8M | +193% |
| Q4 2025 | $764M | +67% |
| Q3 2025 | $500.9M | +20% |
| Q2 2025 | $531.6M | +276% |
| Q1 2025 | $304.1M | +140% |
| Q4 2024 | $457.2M | +54% |
PLTR has the edge over CHKP on cash flow, with more consistent year-over-year improvement.
CHKP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.5% | -2.6M shares |
| 1 year | -6.3% | -6.9M shares |
| 3 years | -13% | -15.7M shares |
| 5 years | -23% | -31.3M shares |
| Available history | -31% | -47.3M shares |
CHKP has the edge over PLTR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $324.9M |
| Q1 2026 | $325M |
| Q4 2025 | $425M |
| Q3 2025 | $366.8M |
| Q2 2025 | $325M |
| Q1 2025 | $325M |
| Q4 2024 | $324.9M |
| Q3 2024 | $325M |
CHKP spent $1.4B buying back its own shares over the past year, up 11% from the year before.
PLTR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +5.2M shares |
| 1 year | +0.1% | +2.9M shares |
| 3 years | +11% | +248M shares |
| 5 years | +31% | +610M shares |
| Available history | +184% | +1.7B shares |
PLTR has 2.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $19.2M |
| Q3 2025 | $19.2M |
| Q2 2025 | $18.6M |
| Q1 2025 | $18M |
| Q4 2024 | $18.6M |
| Q3 2024 | $18.9M |
| Q2 2024 | $17.7M |
| Q1 2024 | $9M |
CHKP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
CHKP's net debt is about 1.5 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
PLTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -1.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.9x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.3x | Net Cash |
| Q4 2024 | -6.1x | Net Cash |
PLTR has the edge over CHKP on leverage, with a lower net debt burden relative to earnings.
CHKP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 62.8 | Neutral |
CHKP's weekly RSI is 55 (neutral) and its Stochastic is 63 (neutral).
PLTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.4 | Neutral |
| Stochastic | 47.4 | Neutral |
PLTR's weekly RSI is 51 (neutral) and its Stochastic is 47 (neutral).
CHKP PE vs Technology Sector
| Metric | CHKP | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 28x | 46% below |
| PE % | 8 | 35 | 27 pts below |
CHKP has the edge over PLTR on valuation relative to its sector.
PLTR PE vs Technology Sector
| Metric | PLTR | Sector median | Relative |
|---|---|---|---|
| PE | 120x | 28x | 331% above |
| PE % | 1 | 38 | 37 pts below |
PLTR is trading at 120x earnings, a 331% premium to the Technology sector's median of 28x.
CHKP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $142.4 | 3.6% above |
| 20 week MA | $136.6 | 8% above |
| 50 week MA | $147.6 | 0.1% below |
| 100 week MA | $177.1 | 17% below |
| 200 week MA | $164.5 | 10% below |
CHKP has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 10% below its 200-week average.
PLTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $185.8 | 7.6% below |
| 20 week MA | $167.6 | 2.4% above |
| 50 week MA | $157.1 | 9.2% above |
| 100 week MA | $143.8 | 19% above |
| 200 week MA | $83.3 | 106% above |
PLTR has the edge over CHKP on trend strength, trading above more of its moving averages.
CHKP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $111.8 | $134.8 | +21% |
| 2021 | $134.8 | $114.9 | -15% |
| 2022 | $114.9 | $127.0 | +11% |
| 2023 | $127.0 | $152.8 | +20% |
| 2024 | $152.8 | $187.9 | +23% |
| 2025 | $187.9 | $189.6 | +0.9% |
| 2026 YTD | $189.6 | $147.5 | -22% |
CHKP has finished higher in five of the last six years. It's down 22% so far in 2026.
PLTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.20 | $27.8 | +202% |
| 2021 | $27.8 | $18.9 | -32% |
| 2022 | $18.9 | $6.29 | -67% |
| 2023 | $6.29 | $17.2 | +173% |
| 2024 | $17.2 | $79.1 | +361% |
| 2025 | $79.1 | $188.7 | +139% |
| 2026 YTD | $188.7 | $171.6 | -9.1% |
PLTR has the edge over CHKP on returns for 2026, with the stronger performance.